rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.14412/1995-4484-2019-250-254rsp-2722Research ArticleПЕРЕДОВАЯLEADING ARTICLEМожно ли предотвратить развитие псориатического артрита у пациентов с псориазом?Can the development of psoriatic arthritis be prevented in patients with psoriasis?НасоновЕ. Л.NasonovE. L.

115522, Москва, Каширское шоссе, 34А.

119991, Москва, ул. Трубецкая, 8, стр. 2.

34A, Kashirskoe Shosse, Moscow, 115522.

8, Trubetskaya Str., Build. 2, Moscow, 119991.

nasonov@irramn.ruКоротаеваТ. В.KorotaevaT. V.

115522, Москва, Каширское шоссе, 34А.

34A, Kashirskoe Shosse, Moscow, 115522.

ЛилаА. М.LilaA. M.

115522, Москва, Каширское шоссе, 34А.

34A, Kashirskoe Shosse, Moscow, 115522.

КубановА. А.KubanovA. A.

107076, Москва, ул. Короленко, 6, стр. 6.

6, Korolenko Str., Build. 6, Moscow, 107076.

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)РоссияV.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)Russian FederationФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationФГБНУ «Государственный научный центр дерматовенерологии и косметологии» Минздрава РоссииРоссияState Scientific Center for Dermatovenerology and Cosmetology, Ministry of Health of RussiaRussian Federation201908072019573250254Copyright © Насонов Е.Л., Коротаева Т.В., Лила А.М., Кубанов А.А., 20192019Насонов Е.Л., Коротаева Т.В., Лила А.М., Кубанов А.А.Nasonov E.L., Korotaeva T.V., Lila A.M., Kubanov A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/2722

Псориатический артрит (ПсА) – хроническое иммуновоспалительное заболевание, которое, с одной стороны, рассматривается как наиболее частая коморбидная патология при псориазе в рамках «системной псориатической болезни», а с другой – классифицируется как клиническая форма спондилоартритов и находится на стыке фундаментальных проблем ревматологии и дерматологии. Изучение эволюции псориаза в направлении развития ПсА является приоритетным направлением исследований в ревматологии и дерматологии, имеющим важное значение для расшифровки природы гетерогенности и механизмов иммунопатогенеза этих заболеваний и разработки новых методов персонифицированной терапии на разных стадиях заболеваний.

Psoriatic arthritis (PsA) is a chronic immunoinflammatory disease that, on the one hand, is considered as the most common comorbidity in psoriasis as part of systemic psoriatic disease, and, on the other, is classified as a clinical form of spondyloarthritis and lies at the interface of the basic problems of rheumatology and dermatology. The study of the evolution of psoriasis in relation to the development of PsA is a research priority area in rheumatology and dermatology, which is important for deciphering the nature of heterogeneity and the immunopathogenesis mechanisms of these diseases and for developing novel methods of personalized therapy at different stages of diseases.

псориазпсориатический артритиммуногенетикабиомаркерыpsoriasispsoriatic arthritisimmunogeneticsbiomarkersReferencesScarpa R, Ayala F, Caporaso N, Olivieri I. Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol. 2006 Feb;33(2):210-2.Scarpa R, Ayala F, Caporaso N, Olivieri I. Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol. 2006 Feb;33(2):210-2.Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957-70. doi: 10.1056/NEJMra1505557Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957-70. doi: 10.1056/NEJMra1505557Liang Y, Sarkar MK, Tsoi LC, Gudjonsson JE. Psoriasis: a mixed autoimmune and autoinflammatory disease. Curr Opin Immunol. 2017;49:1-8. doi: 10.1016/j.coi.2017.07.007Liang Y, Sarkar MK, Tsoi LC, Gudjonsson JE. Psoriasis: a mixed autoimmune and autoinflammatory disease. Curr Opin Immunol. 2017;49:1-8. doi: 10.1016/j.coi.2017.07.007Chimenti MS, Caso F, Alivernini S, et al. Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease. Autoimmun Rev. 2019;18(6):565-75. doi: 10.1016/j.autrev.2018.11.007Chimenti MS, Caso F, Alivernini S, et al. Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease. Autoimmun Rev. 2019;18(6):565-75. doi: 10.1016/j.autrev.2018.11.007Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018;391(10136):2273-84. doi: 10.1016/S0140-6736(18)30830-4Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018;391(10136):2273-84. doi: 10.1016/S0140-6736(18)30830-4Christophers E, van de Kerkhof PCM. Severity, heterogeneity and systemic inflammation in psoriasis. J Eur Acad Dermatol Venereol. 2019;33(4):643-7. doi: 10.1111/jdv.15339Christophers E, van de Kerkhof PCM. Severity, heterogeneity and systemic inflammation in psoriasis. J Eur Acad Dermatol Venereol. 2019;33(4):643-7. doi: 10.1111/jdv.15339Tillett W, Charlton R, Nightingale A, et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford). 2017;56(12):2109-13. doi: 10.1093/rheumatology/kex323Tillett W, Charlton R, Nightingale A, et al. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford). 2017;56(12):2109-13. doi: 10.1093/rheumatology/kex323Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74:1045-50. doi: 10.1136/annrheumdis-2013-204858Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74:1045-50. doi: 10.1136/annrheumdis-2013-204858Burgers LE, Raza K, van der Helm-van Mil AH. Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives. RMD Open. 2019;5(1):e000870. doi: 10.1136/rmdopen-2018-000870Burgers LE, Raza K, van der Helm-van Mil AH. Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives. RMD Open. 2019;5(1):e000870. doi: 10.1136/rmdopen-2018-000870Van Steenbergen HW, da Silva JAP, Huizinga TWJ, van der Helmvan Mil AHM. Preventing progression from arthralgia to arthritis: targeting the right patients. Nat Rev Rheumatol. 2018;14(1):32-41. doi: 10.1038/nrrheum.2017.185Van Steenbergen HW, da Silva JAP, Huizinga TWJ, van der Helmvan Mil AHM. Preventing progression from arthralgia to arthritis: targeting the right patients. Nat Rev Rheumatol. 2018;14(1):32-41. doi: 10.1038/nrrheum.2017.185Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15(3):153-66. doi: 10.1038/s41584-019-0175-0Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15(3):153-66. doi: 10.1038/s41584-019-0175-0Scher JU. The 2018 landscape of RA, PsA, and SpA pathogenesis. Curr Opin Rheumatol. 2018;30:57-8. doi: 10.1097/BOR.0000000000000461Scher JU. The 2018 landscape of RA, PsA, and SpA pathogenesis. Curr Opin Rheumatol. 2018;30:57-8. doi: 10.1097/BOR.0000000000000461Насонов ЕЛ. Новые возможности фармакотерапии иммуновоспалительных ревматических заболеваний: фокус на ингибиторы интерлейкина 17. Научно-практическая ревматология. 2017;55(1):68-86 [Nasonov EL. New possibilities of pharmacotherapy for immunoinflammatory rheumatic diseases: A focus on inhibitors of interleukin-17. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(1):68-86 (In Russ.)]. doi: 10.14412/1995-4484-2017-68-86Насонов ЕЛ. Новые возможности фармакотерапии иммуновоспалительных ревматических заболеваний: фокус на ингибиторы интерлейкина 17. Научно-практическая ревматология. 2017;55(1):68-86 [Nasonov EL. New possibilities of pharmacotherapy for immunoinflammatory rheumatic diseases: A focus on inhibitors of interleukin-17. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(1):68-86 (In Russ.)]. doi: 10.14412/1995-4484-2017-68-86Kim HJ, Lebwohl MG. Biologics and Psoriasis: The Beat Goes On. Dermatol Clin. 2019;37(1):29-36. doi: 10.1016/j.det.2018.07.004Kim HJ, Lebwohl MG. Biologics and Psoriasis: The Beat Goes On. Dermatol Clin. 2019;37(1):29-36. doi: 10.1016/j.det.2018.07.004FitzGerald O, Ritchlin C. Opportunities and challenges in the treatment of psoriatic arthritis. Best Pract Res Clin Rheumatol. 2018;32(3):440-52. doi: 10.1016/j.berh.2019.03.001FitzGerald O, Ritchlin C. Opportunities and challenges in the treatment of psoriatic arthritis. Best Pract Res Clin Rheumatol. 2018;32(3):440-52. doi: 10.1016/j.berh.2019.03.001Singh JA, Guyatt G, Ogdie A, et al. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheum. 2019;71(1):5-32. doi: 10.1002/art.40726Singh JA, Guyatt G, Ogdie A, et al. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheum. 2019;71(1):5-32. doi: 10.1002/art.40726Van den Bosch F, Coates L. Clinical management of psoriatic arthritis. Lancet. 2018;391(10136):2285-94. doi: 10.1016/S0140-6736(18)30949-8Van den Bosch F, Coates L. Clinical management of psoriatic arthritis. Lancet. 2018;391(10136):2285-94. doi: 10.1016/S0140-6736(18)30949-8Okhovat JP, Ogdie A, Reddy SM, et al. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: benefits and challenges of combined rheumatology-dermatology clinics. J Rheumatol. 2017;44(5):693-4. doi: 10.3899/jrheum.170148Okhovat JP, Ogdie A, Reddy SM, et al. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: benefits and challenges of combined rheumatology-dermatology clinics. J Rheumatol. 2017;44(5):693-4. doi: 10.3899/jrheum.170148Siegel EL, Orbai AM, Ritchlin CT. Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis. Curr Opin Rheumatol. 2015;27:111-7. doi: 10.1097/BOR.0000000000000155Siegel EL, Orbai AM, Ritchlin CT. Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis. Curr Opin Rheumatol. 2015;27:111-7. doi: 10.1097/BOR.0000000000000155Насонов ЕЛ. Проблемы иммунопатологии ревматоидного артрита: эволюция болезни. Научно-практическая ревматология. 2017;55(3):277-94 [Nasonov EL. Problems of rheumatoid arthritis immunopathology: Evolution of the disease. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(3):277-94 (In Russ.)]. doi: 10.14412/1995-4484-2017-277-294Насонов ЕЛ. Проблемы иммунопатологии ревматоидного артрита: эволюция болезни. Научно-практическая ревматология. 2017;55(3):277-94 [Nasonov EL. Problems of rheumatoid arthritis immunopathology: Evolution of the disease. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(3):277-94 (In Russ.)]. doi: 10.14412/1995-4484-2017-277-294Boeters DM, Raza K, van der Helm-van Mil AHM. Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art. RMD Open. 2017;3(2):e000479. doi: 10.1136/rmdopen-2017-000479. eCollection 2017.Boeters DM, Raza K, van der Helm-van Mil AHM. Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art. RMD Open. 2017;3(2):e000479. doi: 10.1136/rmdopen-2017-000479. eCollection 2017.Deane KD, El-Gabalawy H. Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE. Nat Rev Rheumatol. 2014;10:212-28. doi: 10.1038/nrrheum.2014.6Deane KD, El-Gabalawy H. Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE. Nat Rev Rheumatol. 2014;10:212-28. doi: 10.1038/nrrheum.2014.6Watad A, Bridgewood C, Russell T, et al. The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science. Front Immunol. 2018;9:2668. doi: 10.3389/fimmu.2018.02668Watad A, Bridgewood C, Russell T, et al. The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science. Front Immunol. 2018;9:2668. doi: 10.3389/fimmu.2018.02668Olsen NJ, Karp DR. Autoantibodies and SLE: the threshold for disease. Nat Rev Rheumatol. 2014;10:181-6. doi: 10.1038/nrrheum.2013.184Olsen NJ, Karp DR. Autoantibodies and SLE: the threshold for disease. Nat Rev Rheumatol. 2014;10:181-6. doi: 10.1038/nrrheum.2013.184Winthrop KL, Weinblatt ME, Crow MK, et al. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018. Ann Rheum Dis. 2019 Feb 2. pii: annrheumdis-2018-214280. doi: 10.1136/annrheumdis-2018-214280Winthrop KL, Weinblatt ME, Crow MK, et al. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018. Ann Rheum Dis. 2019 Feb 2. pii: annrheumdis-2018-214280. doi: 10.1136/annrheumdis-2018-214280Eder L, Haddad A, Rosen CF, et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheum. 2016;68(4):915-23. doi: 10.1002/art.39494Eder L, Haddad A, Rosen CF, et al. The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study. Arthritis Rheum. 2016;68(4):915-23. doi: 10.1002/art.39494Aydin SZ, Castillo-Gallego C, Ash ZR, et al. Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. Dermatology. 2012;225(3):231-5. doi: 10.1159/000343607Aydin SZ, Castillo-Gallego C, Ash ZR, et al. Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy. Dermatology. 2012;225(3):231-5. doi: 10.1159/000343607Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017 Mar;76(3):377-90. doi: 10.1016/j.jaad.2016.07.064Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017 Mar;76(3):377-90. doi: 10.1016/j.jaad.2016.07.064Eder L, Polachek A, Rosen CF, et al. The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheum. 2017;69(3):622-9. doi: 10.1002/art.39973. Erratum in: Arthritis Rheum. 2019;71(4):625. doi: 10.1002/art.40887Eder L, Polachek A, Rosen CF, et al. The development of psoriatic arthritis in patients with psoriasis is preceded by a period of nonspecific musculoskeletal symptoms: a prospective cohort study. Arthritis Rheum. 2017;69(3):622-9. doi: 10.1002/art.39973. Erratum in: Arthritis Rheum. 2019;71(4):625. doi: 10.1002/art.40887Thorarensen SM, Lu N, Ogdie A, et al. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2017;76:521-5. doi: 10.1136/annrheumdis-2016-209334Thorarensen SM, Lu N, Ogdie A, et al. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis. Ann Rheum Dis. 2017;76:521-5. doi: 10.1136/annrheumdis-2016-209334Van Mechelen M, Lories RJ. Microtrauma: no longer to be ignored in spondyloarthritis? Curr Opin Rheumatol. 2016;28:176-80. doi: 10.1097/BOR.0000000000000254Van Mechelen M, Lories RJ. Microtrauma: no longer to be ignored in spondyloarthritis? Curr Opin Rheumatol. 2016;28:176-80. doi: 10.1097/BOR.0000000000000254FitzGerald O, Haroon M, Giles JT, Winchester R. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015;17:115. doi: 10.1186/s13075-015-0640-3FitzGerald O, Haroon M, Giles JT, Winchester R. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015;17:115. doi: 10.1186/s13075-015-0640-3Stuart PE, Nair RP, Tsoi LC, et al. Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture. Am J Hum Genet. 2015;97(6):816-36. doi: 10.1016/j.ajhg.2015.10.019Stuart PE, Nair RP, Tsoi LC, et al. Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture. Am J Hum Genet. 2015;97(6):816-36. doi: 10.1016/j.ajhg.2015.10.019Aterido A, Canete JD, Tornero J, et al. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. Ann Rheum Dis. 2019;78(3). pii: e214158. doi: 10.1136/annrheumdis-2018-214158. Epub 2018 Dec 14.Aterido A, Canete JD, Tornero J, et al. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis. Ann Rheum Dis. 2019;78(3). pii: e214158. doi: 10.1136/annrheumdis-2018-214158. Epub 2018 Dec 14.Feld J, Chandran V, Haroon N, et al. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol. 2018;14(6):363-71. doi: 10.1038/s41584-018-0006-8Feld J, Chandran V, Haroon N, et al. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol. 2018;14(6):363-71. doi: 10.1038/s41584-018-0006-8Blauvelt A, Chiricozzi A. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis. Clin Rev Allergy Immunol. 2018;55(3):379-90. doi: 10.1007/s12016-018-8702-3Blauvelt A, Chiricozzi A. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis. Clin Rev Allergy Immunol. 2018;55(3):379-90. doi: 10.1007/s12016-018-8702-3Schön MP, Erpenbeck L. The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis. Front Immunol. 2018;9:1323. doi: 10.3389/fimmu.2018.01323Schön MP, Erpenbeck L. The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis. Front Immunol. 2018;9:1323. doi: 10.3389/fimmu.2018.01323Mylle S, Grine L, Speeckaert R, et al. Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly. Am J Clin Dermatol. 2018;19(5):625-37. doi: 10.1007/s40257-018-0366-5Mylle S, Grine L, Speeckaert R, et al. Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly. Am J Clin Dermatol. 2018;19(5):625-37. doi: 10.1007/s40257-018-0366-5Mattozzi C, Salvi M, D’Epiro S, et al. Importance of regulatory T cells in the pathogenesis of psoriasis: review of the literature. Dermatology. 2013;227(2):134-45. doi: 10.1159/000353398Mattozzi C, Salvi M, D’Epiro S, et al. Importance of regulatory T cells in the pathogenesis of psoriasis: review of the literature. Dermatology. 2013;227(2):134-45. doi: 10.1159/000353398Насонов ЕЛ, Александрова ЕН, Авдеева АС, Рубцов ЮП. Т-регуляторные клетки при ревматоидном артрите. Научно-практическая ревматология. 2014;52(4):430-7 [Nasonov EL, Aleksandrova EN, Avdeeva AS, Rubtsov YuP. T regulatory cells in rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(4):430-7 (In Russ.)]. doi: 10.14412/1995-4484-2014-430-437Насонов ЕЛ, Александрова ЕН, Авдеева АС, Рубцов ЮП. Т-регуляторные клетки при ревматоидном артрите. Научно-практическая ревматология. 2014;52(4):430-7 [Nasonov EL, Aleksandrova EN, Avdeeva AS, Rubtsov YuP. T regulatory cells in rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(4):430-7 (In Russ.)]. doi: 10.14412/1995-4484-2014-430-437Авдеева АС, Рубцов ЮП, Дыйканов ДТ, Насонов ЕЛ. Клинико-патогенетическое значение Foxр3+ регуляторных Т-клеток при ревматоидном артрите. Научно-практическая ревматология. 2016;54(4):442-55 [Avdeeva AS, Rubtsov YuP, Dyikanov DT, Nasonov EL. The clinical and pathogenetic value of Foxp3+ T regulatory cells in rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(4):442-55 (In Russ.)]. doi: 10.14412/1995-4484-2016-442-455Авдеева АС, Рубцов ЮП, Дыйканов ДТ, Насонов ЕЛ. Клинико-патогенетическое значение Foxр3+ регуляторных Т-клеток при ревматоидном артрите. Научно-практическая ревматология. 2016;54(4):442-55 [Avdeeva AS, Rubtsov YuP, Dyikanov DT, Nasonov EL. The clinical and pathogenetic value of Foxp3+ T regulatory cells in rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(4):442-55 (In Russ.)]. doi: 10.14412/1995-4484-2016-442-455Pereira LMS, Gomes STM, Ishak R, Vallinoto ACR. Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis. Front Immunol. 2017;8:605. doi: 10.3389/fimmu.2017.00605Pereira LMS, Gomes STM, Ishak R, Vallinoto ACR. Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis. Front Immunol. 2017;8:605. doi: 10.3389/fimmu.2017.00605Scher JU, Littman DR, Abramson SB. Microbiome in inflammatory arthritis and human rheumatic diseases. Arthritis Rheum. 2016;68:35-45. doi: 10.1002/art.39259Scher JU, Littman DR, Abramson SB. Microbiome in inflammatory arthritis and human rheumatic diseases. Arthritis Rheum. 2016;68:35-45. doi: 10.1002/art.39259Li WQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis. 2013;72:1200-5. doi: 10.1136/annrheumdis-2012-202143Li WQ, Han JL, Chan AT, Qureshi AA. Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis. 2013;72:1200-5. doi: 10.1136/annrheumdis-2012-202143Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheum. 2015;67(1):128-39. doi: 10.1002/art.38892Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheum. 2015;67(1):128-39. doi: 10.1002/art.38892Авдеева АС. ИФНγ-индуцируемый белок 10 (IP-10) при ревматоидном артрите: обзор литературы и собственные данные. Научно-практическая ревматология. 2017;55(6):655-61 [Avdeeva AS. IFN-γ-induced protein 10 (IP-10) in rheumatoid arthritis: literature review and the authors' own data. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(6):655-661 (In Russ.)]. doi: 10.14412/1995-4484-2017-655-661Авдеева АС. ИФНγ-индуцируемый белок 10 (IP-10) при ревматоидном артрите: обзор литературы и собственные данные. Научно-практическая ревматология. 2017;55(6):655-61 [Avdeeva AS. IFN-γ-induced protein 10 (IP-10) in rheumatoid arthritis: literature review and the authors' own data. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017;55(6):655-661 (In Russ.)]. doi: 10.14412/1995-4484-2017-655-661Abji F, Pollock RA, Liang K, et al. Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis. Arthritis Rheum. 2016;68:2911-6. doi: 10.1002/art.39800Abji F, Pollock RA, Liang K, et al. Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis. Arthritis Rheum. 2016;68:2911-6. doi: 10.1002/art.39800Cretu D, Gao L, Liang K, et al. Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers. Arthritis Care Res (Hoboken). 2018;70(3):454-61. doi: 10.1002/acr.23298Cretu D, Gao L, Liang K, et al. Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers. Arthritis Care Res (Hoboken). 2018;70(3):454-61. doi: 10.1002/acr.23298Cretu D, Liang K, Saraon P, et al. Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clin Proteomics. 2015;12(1):1. doi: 10.1186/1559-0275-12-1Cretu D, Liang K, Saraon P, et al. Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clin Proteomics. 2015;12(1):1. doi: 10.1186/1559-0275-12-1Frasca L, Palazzo R, Chimenti MS, et al. Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. Front Immunol. 2018;9:1936. doi: 10.3389/fimmu.2018.01936Frasca L, Palazzo R, Chimenti MS, et al. Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. Front Immunol. 2018;9:1936. doi: 10.3389/fimmu.2018.01936Yuan Y, Qiu J, Lin ZT, et al. Identification of Novel Autoantibodies Associated With Psoriatic Arthritis. Arthritis Rheum. 2019;71(6):941-51. doi: 10.1002/art.40830Yuan Y, Qiu J, Lin ZT, et al. Identification of Novel Autoantibodies Associated With Psoriatic Arthritis. Arthritis Rheum. 2019;71(6):941-51. doi: 10.1002/art.40830Gisondi P, Tinazzi I, El-Dalati G, et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis. 2008;67:26-30. doi: 10.1136/ard.2007.075101Gisondi P, Tinazzi I, El-Dalati G, et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis. 2008;67:26-30. doi: 10.1136/ard.2007.075101Simon D, Faustini F, Kleyer A, et al. Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis. Ann Rheum Dis. 2016;75(4):660-6. doi: 10.1136/annrheumdis-2014-206347Simon D, Faustini F, Kleyer A, et al. Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis. Ann Rheum Dis. 2016;75(4):660-6. doi: 10.1136/annrheumdis-2014-206347Tinazzi I, McGonagle D, Biasi D, et al. Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J Rheumatol. 2011;38(12):2691-2. doi: 10.3899/jrheum.110505Tinazzi I, McGonagle D, Biasi D, et al. Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J Rheumatol. 2011;38(12):2691-2. doi: 10.3899/jrheum.110505Araujo EG, Englbrecht M, Hoepken S, et al. Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study. Semin Arthritis Rheum. 2019;48(4):632-7. doi: 10.1016/j.semarthrit.2018.05.011Araujo EG, Englbrecht M, Hoepken S, et al. Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study. Semin Arthritis Rheum. 2019;48(4):632-7. doi: 10.1016/j.semarthrit.2018.05.011Колтакова АД. Регистры псориатического артрита. Обзор литературы. Научно-практическая ревматология. 2019;57(2):210-7 [Koltakova AD. Registers of psoriatic arthritis. Literature review. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2019;57(2):210-7 (In Russ.)]. doi: 10.14412/1995-4484-2019-210-217Колтакова АД. Регистры псориатического артрита. Обзор литературы. Научно-практическая ревматология. 2019;57(2):210-7 [Koltakova AD. Registers of psoriatic arthritis. Literature review. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2019;57(2):210-7 (In Russ.)]. doi: 10.14412/1995-4484-2019-210-217

The authors declare that there are no conflicts of interest present.